Alison Bevan, M.D., Ph.D.
Associate Physician Diplomate
To see if Alison Bevan is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
Adventist Health and Rideout Cancer Center
Adventist Health/Rideout Cancer Center
618 5th Street
Marysville, CA 95901
Clinical Interests
Dr. Bevan is a radiation oncologist who works carefully with the cancer care teams at Adventist Health and Rideout Cancer Center to develop targeted treatment plans specific to each patient’s diagnosis and needs. She oversees treatment to ensure accuracy, carefully monitors progress, and identifies and treats any side effects.
Division
Radiation Oncology
Undergraduate School
B.A., Chemistry, University of Vermont, Burlington VT 1989
Medical School
M.D., Stanford University School of Medicine, Palo Alto CA 1997
Other School
Ph.D., Biochemistry, Stanford University School of Medicine, Palo Alto CA 1997
Internship
Internal Medicine, Stanford University Medical Center, Palo Alto CA 1997-1998
Residency
Radiation Oncology, Stanford University Medical Center, Palo Alto CA 1998-2002
Young Investigator Award, Ortho Biotech, Inc., Janssen Research Foundation and Eastern Cooperative Oncology Group, 2000
Research Resident Award, Radiological Society of North America, 2000
Park CC, Yom SS, Podgorsak MB, Harris E, Price RA Jr, Bevan A, Pouliot J, Konski AA, Wallner PE; Electronic Brachytherapy Working Group. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):963-72. doi:10.1016/j.ijrobp.2009.10.068. PMID:20206016.
Chan LW, Rabban J, Hwang ES, Bevan A, Alvarado M, Ewing C, Esserman L, Fowble B. Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins? Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):25-30. doi:10.1016/j.ijrobp.2010.01.044. Epub 2010 Jun 18. PMID:20646871.
Bucci MK, Bevan A, Roach M 3rd. Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin. 2005 Mar-Apr;55(2):117-34. doi:10.3322/canjclin.55.2.117. PMID:15761080.
Bevan A, Brenner C, Fuller RS. Quantitative assessment of enzyme specificity in vivo: P2 recognition by Kex2 protease defined in a genetic system. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10384-9. doi:10.1073/pnas.95.18.10384. PMID:9724712.
Brenner C, Bevan A, Fuller RS. Biochemical and genetic methods for analyzing specificity and activity of a precursor-processing enzyme: yeast Kex2 protease, kexin. Methods Enzymol. 1994;244:152-67. doi:10.1016/0076-6879(94)44013-1. PMID:7845204.
Brenner C, Bevan A, Fuller RS. One-step site-directed mutagenesis of the Kex2 protease oxyanion hole. Curr Biol. 1993 Aug 1;3(8):498-506. doi:10.1016/0960-9822(93)90040-u. Erratum in: Curr Biol. 1993 Sep 1;3(9): 634. PMID:15335687.
Chen A, Park C, Bevan A, Margolis LW. Breast Cancer Handbook of Evidence-Based Radiation Oncology, Springer Science & Business Media, LLC. 2007.
Chung HT, Bevan A. Hodgkin’s Lymphoma Handbook of Evidence-Based Radiation Oncology, Springer Science & Business Media, LLC. 2007.
Chung HT, Bevan A. Non-Hodgkin’s Lymphoma Handbook of Evidence-Based Radiation Oncology, Springer Science & Business Media, LLC. 2007.
Fowble B, Bevan A, Alvarado M, Melisko M. Cancer of the Breast. Leibel and Philips Textbook of Radiation Oncology, 3rd Edition, Elsevier Saunders. 2010.